Lisa Wilson | Investor Relations |
Scott Tarriff | Founder, Chief Executive Officer and Director |
David Pernock | President, Chief Commercial Officer |
Pete Meyers | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer |
Dan Busby | Randall |
Brandon Folkes | Cantor Fitzgerald |
Good day and welcome to today’s program. My name is Keith and I will be your conference operator. At this time I'd like to welcome everyone to Eagle Pharmaceuticals’ Fourth Quarter and Full Year 2018 Earnings Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today February 28, 2019. It is now my pleasure to turn the floor over to Ms.